Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index; 65 of the 154 sources its claims cite were checked for support.

Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review

Open access
Eberle, Claudia, Löhnert, Maxine, Stichling, Stefanie · 2021 · JMIR mHealth and uHealth

Published version of a preprint

Abstract

Background: According to the World Health Organization, the worldwide prevalence of diabetes mellitus (DM) is increasing dramatically and DM comprises a large part of the global burden of disease. At the same time, the ongoing digitalization that is occurring in society today offers novel possibilities to deal with this challenge, such as the creation of mobile health (mHealth) apps. However, while a great variety of DM-specific mHealth apps exist, the evidence in terms of their clinical effectiveness is still limited. Objective: The objective of this review was to evaluate the clinical effectiveness of mHealth apps in DM management by analyzing health-related outcomes in patients diagnosed with type 1 DM (T1DM), type 2 DM (T2DM), and gestational DM. Methods: A scoping review was performed. A systematic literature search was conducted in MEDLINE (PubMed), Cochrane Library, EMBASE, CINAHL, and Web of Science Core Collection databases for studies published between January 2008 and October 2020. The studies were categorized by outcomes and type of DM. In addition, we carried out a meta-analysis to determine the impact of DM-specific mHealth apps on the management of glycated hemoglobin (HbA1c). Results: In total, 27 studies comprising 2887 patients were included. We analyzed 19 randomized controlled trials, 1 randomized crossover trial, 1 exploratory study, 1 observational study, and 5 pre-post design studies. Overall, there was a clear improvement in HbA1c values in patients diagnosed with T1DM and T2DM. In addition, positive tendencies toward improved self-care and self-efficacy as a result of mHealth app use were found. The meta-analysis revealed an effect size, compared with usual care, of a mean difference of –0.54% (95% CI –0.8 to –0.28) for T2DM and –0.63% (95% CI –0.93 to –0.32) for T1DM. Conclusions: DM-specific mHealth apps improved the glycemic control by significantly reducing HbA1c values in patients with T1DM and T2DM patients. In general, mHealth apps effectively enhanced DM management. However, further research in terms of clinical effectiveness needs to be done in greater detail.

Overview

CoChat Summary

TL;DR

This scoping review of 27 studies comprising 2887 patients found that diabetes-specific mHealth apps improved glycemic control, with meta-analytic HbA1c reductions versus usual care for type 2 and type 1 diabetes mellitus. Evidence for other outcomes was limited or inconclusive.

Key findings

  • Across 27 studies, HbA1c meta-analysis showed a mean difference of –0.54% (95% CI –0.8 to –0.28) for T2DM (8 studies) and –0.63% (95% CI –0.93 to –0.32) for T1DM (2 studies), compared with usual care.
  • In T1DM, 3 of 7 studies found significant within-group HbA1c improvements (mean differences: –1.1%, P<.001; –0.3%, P<.001; –0.3%, P=.04), yielding an average HbA1c of 7.73%; 2 studies found significant between-group differences favoring app intervention (P<.001; –0.67%, P<.001).
  • In T2DM, 11 studies reported a within-group HbA1c decrease (mean difference –0.42%), but only 1 reported a significant change of –1.1% (P<.001); 7 of 11 studies with control groups reported significant between-group differences (mean difference –0.78%, –1.51 to –0.35). Fasting blood glucose improved significantly in 2 studies (–28.23 mg/dL, P<.001; –9.6 mg/dL, P=.019), while none of 7 studies reporting blood pressure found significant differences.
  • In GDM, data were limited: 1 study found a significant between-group HbA1c difference favoring the app (–1.3% vs –0.6%, P<.001), while another found no significant difference; positive tendencies were reported for self-care and self-efficacy overall.

Methods

  • Scoping review with a systematic literature search in MEDLINE (PubMed), Cochrane Library, EMBASE, CINAHL, and Web of Science Core Collection for studies published January 2008 to October 2020, restricted to German and English; screening and selection were done by two independent reviewers.
  • Included primary research studies (randomized controlled trials, exploratory studies, observational studies, and pre-post design studies) reporting clinical effectiveness of DM-specific mHealth apps in T1DM, T2DM, and GDM, specifying app features and health effects; excluded posters, comments, study protocols, duplicates, and studies focused on DM diagnosis or prevention.
  • Data were extracted on author, year, study design, intervention and control groups, baseline and follow-up HbA1c, DM type, sample size, and main findings; studies were synthesized by outcome, and a meta-analysis pooled studies with mHealth-app-only intervention groups versus usual care that reported HbA1c changes as percentages.

Limitations

  • The paper states a major limitation is the small sample size, especially for GDM: only 4 GDM studies were included, they reported predominantly different outcomes, and no effects of mHealth app use could be determined for GDM.
  • The paper states that the quality of included studies was not assessed, so it cannot judge whether an effect was based on poor study quality.
  • Evident from the text: heterogeneity in DM type, study design, participant numbers, app features, and co-interventions (eg, web portals, HCP feedback, Bluetooth-enabled devices) prevented distinguishing a relationship between specific app features and health outcomes; data were also limited for hypo- and hyperglycemia, further glycemic control parameters, self-care, and self-efficacy.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2196/23477

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart.
Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart.CC BY · PubMed Central

Verification

Claims the paper makes

38 Valid · 1 Not valid · 39 Not checked · 44 Own results and interpretations

68 more claims · 27 with their cited sources checked

Create a free account to see all 122 claims and to verify the 89 references still open.

See all claims — free account
  • It may state two separate claims as one. 29
  • Probably not a substantial claim. 23
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 70 references

Research works printed but not linked: 8

  1. Meister, S, 2019, GGW, 19, 7
  2. Meister, S, 2016, Pfannstiel MA, Da-Cruz P, Mehlich H. editors. Digitale Transformation von Dienstleistungen im Gesundheitswesen I, 185
  3. Eberle, C, 2020, Stupin J, Schäfer-Graf U, Hummel M. editors, Praxisorientiertes Wissen zu Gestationsdiabetes, Diabetes mellitus Typ 1 und 2, MODY
  4. Hamidian, K, 2013, Keuper F. editor. Digitalisierung und Innovation: Planung, Entstehung, Entwicklungsperspektiven, 1
  5. Scherenberg, V, 2013, Strahlendorfditor. Jahrbuch Health Care Marketing, 115
  6. Gießelmann, K, 2018, Dtsch Arztebl, 115, A538
  7. 10.1055/s-0035-1549513 · DOI
  8. Chomutare, T, 2013, Stud Health Technol Inform, 188, 58

Cited by

See all 160

Metadata

Authors
Eberle, C., Löhnert, M., & Stichling, S.
Affiliations
Fulda University of Applied Sciences (DE)
Corresponding author
Eberle, Claudia
Venue
JMIR mHealth and uHealth
Published
2021-02-15
Volume
9
Issue
2
Pages
e23477
ISSN
2291-5222 (ISSN-L)
OpenAlex
W3109131069
Cited by
160
References
70
Citations by year
2026: 21 · 2025: 39 · 2024: 35 · 2023: 40 · 2022: 20 · 2021: 5
FWCI
3.10
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JMIR mhealth and uhealth (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Strong
  • Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetes mellitus, mobile health apps, type 1 diabetes, type 2 diabetes, gestational diabetes mellitus, HbA1c, glycemic control, self-care, self-efficacy, diabetes management
MeSH terms
Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Self Care, Randomized Controlled Trials as Topic, Telemedicine, Mobile Applications, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.